ReviewCureus2025
Late Jejunojejunal Perforation After Laparoscopic Roux-en-Y Gastric Bypass: A Systematic Narrative Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Short-Term Changes in Migraine Burden After Roux-en-Y Gastric Bypass: A Prospective Cohort Study.Obesity surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Late perforation of the jejunojejunal (JJ) anastomosis after laparoscopic Roux-en-Y gastric bypass (LRYGB) is an exceedingly uncommon but potentially life-threatening complication. The widely non-specific presentation and the vast range of possible causes can delay diagnosis and increase morbidity. In this study, we aim to integrate the results of published literature on late JJ perforation after LRYGB in terms of patients' clinical characteristics, presentation, duration between the RYGB operation and the onset of JJ perforation, possible causes, as well as the outcome of the patients. We performed a comprehensive literature search of PubMed, CINAHL Plus, Embase, and EBSCOhost from inception to October 2025 using terms related to "Roux-en-Y gastric bypass," "jejunojejunal," "JJ," and "perforation." Case reports and case series describing late JJ perforation after LRYGB in adults were eligible. Two reviewers independently screened titles, abstracts, and full texts. Data were extracted on patient characteristics, time from index operation to perforation, predisposing factors, diagnostic tools, operative findings, and outcomes. Evidence was reviewed systematically and then narratively synthesised. A meta-analysis was not possible due to the case-based nature of the available literature. Eight studies reporting 12 patients with late JJ perforation following LRYGB were identified. Most patients were middle-aged females and presented months to years after surgery with severe, acute abdominal pain, with no specific localising signs. Radiological findings were variable and occasionally non-diagnostic. Proposed mechanisms included marginal ulcers, ischaemia, infection, stress, phytobezoar, and tumour implantation. All patients required operative management, most commonly laparoscopic suture repair or revision of the JJ anastomosis, with generally favourable outcomes with early treatment. Although late JJ perforation after LRYGB is exceptionally rare, it should be considered in any patient presenting with an acute abdomen with a past history of bariatric operation, irrespective of the interval since surgery. Early radiological assessment with cross-sectional studies, a low threshold for diagnostic laparoscopy, and urgent surgical intervention are crucial. Standardised reporting of future cases and collaborative registries are required to define incidence, risk factors, and best management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.